{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:27:10Z","timestamp":1793298430427,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glycosyltransferase enzyme GCNT3, has been proposed as a biomarker for prognosis in colorectal cancer (CRC). Our study goes in depth into the molecular basis of GCNT3 role in tumorigenesis and drug resistance, and it explores its potential role as biomarker in epithelial ovarian cancer (EOC). High levels of <jats:italic>GCNT3<\/jats:italic> are associated with increased sensibility to 5-fluoracil in metastatic cells. Accordingly, GCNT3 re-expression leads to the gain of anti-carcinogenic cellular properties by reducing cell growth, invasion and by changing metabolic capacities. Integrated transcriptomic and proteomic analyses reveal that GCNT3 is linked to cellular cycle, mitosis and proliferation, response to drugs and metabolism pathways. The vascular epithelial growth factor A (VEGFA) arises as an attractive partner of GCNT3 functions in cell invasion and resistance. Finally, GCNT3 expression was analyzed in a cohort of 56 EOC patients followed by a meta-analysis of more than one thousand patients. This study reveals that GCNT3 might constitute a prognostic factor also in EOC, since its overexpression is associated with better clinical outcome and response to initial therapy. GCNT3 emerges as an essential glycosylation-related molecule in CRC and EOC progression, with potential interest as a predictive biomarker of response to chemotherapy.<\/jats:p>","DOI":"10.1038\/s41598-018-26468-4","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T11:22:34Z","timestamp":1527247354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance"],"prefix":"10.1038","volume":"8","author":[{"given":"Lara P.","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"S\u00e1nchez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodoro","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mart\u00edn-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mendiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hardisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Reglero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ram\u00edrez de Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"26468_CR1","first-page":"142","volume":"1846","author":"N Jonckheere","year":"2014","unstructured":"Jonckheere, N., Skrypek, N. & Van Seuningen, I. Mucins and tumor resistance to chemotherapeutic drugs. Biochim. Biophys. Acta 1846, 142\u2013151 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"26468_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth, M. A. & Swanson, B. J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45\u201360 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"26468_CR3","first-page":"1581","volume":"40","author":"TT Wissniowski","year":"2012","unstructured":"Wissniowski, T. T. et al. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. Int. J. Oncol. 40, 1581\u20131589 (2012).","journal-title":"Int. J. Oncol."},{"key":"26468_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1165\/rcmb.2006-0334OC","volume":"36","author":"S Tan","year":"2007","unstructured":"Tan, S. & Cheng, P.-W. Mucin biosynthesis: identification of the cis-regulatory elements of human C2GnT-M gene. Am. J. Respir. Cell Mol. Biol. 36, 737\u2013745 (2007).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"26468_CR5","doi-asserted-by":"publisher","first-page":"792672","DOI":"10.1155\/2015\/792672","volume":"2015","author":"U Andergassen","year":"2015","unstructured":"Andergassen, U. et al. Glycosyltransferases as Markers for Early Tumorigenesis. BioMed Res. Int. 2015, 792672 (2015).","journal-title":"BioMed Res. Int."},{"key":"26468_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.embor.7400705","volume":"7","author":"I Brockhausen","year":"2006","unstructured":"Brockhausen, I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 7, 599\u2013604 (2006).","journal-title":"EMBO Rep."},{"key":"26468_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/glycob\/4.6.873","volume":"4","author":"JM Yang","year":"1994","unstructured":"Yang, J. M. et al. Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 4, 873\u2013884 (1994).","journal-title":"Glycobiology"},{"key":"26468_CR8","doi-asserted-by":"publisher","unstructured":"Betge, J. et al. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. Virchows Arch. Int. J. Pathol., https:\/\/doi.org\/10.1007\/s00428-016-1970-5 (2016).","DOI":"10.1007\/s00428-016-1970-5"},{"key":"26468_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fonc.2015.00138","volume":"5","author":"A Vasconcelos-Dos-Santos","year":"2015","unstructured":"Vasconcelos-Dos-Santos, A. et al. Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer. Front. Oncol. 5, 138 (2015).","journal-title":"Front. Oncol."},{"key":"26468_CR10","doi-asserted-by":"publisher","first-page":"e107941","DOI":"10.1371\/journal.pone.0107941","volume":"9","author":"T Liu","year":"2014","unstructured":"Liu, T. et al. The transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasis. PloS One 9, e107941 (2014).","journal-title":"PloS One"},{"key":"26468_CR11","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1038\/sj.onc.1209350","volume":"25","author":"M-C Huang","year":"2006","unstructured":"Huang, M.-C. et al. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene 25, 3267\u20133276 (2006).","journal-title":"Oncogene"},{"key":"26468_CR12","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1158\/0008-5472.CAN-15-2820","volume":"76","author":"CV Rao","year":"2016","unstructured":"Rao, C. V. et al. Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. Cancer Res. 76, 1965\u20131974 (2016).","journal-title":"Cancer Res."},{"key":"26468_CR13","first-page":"1","volume":"51","author":"M Gonz\u00e1lez-Vallinas","year":"2015","unstructured":"Gonz\u00e1lez-Vallinas, M. et al. Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer. Eur. J. Cancer Oxf. Engl. 1990 51, 1\u20138 (2015).","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"key":"26468_CR14","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1074\/jbc.274.5.3215","volume":"274","author":"JC Yeh","year":"1999","unstructured":"Yeh, J. C., Ong, E. & Fukuda, M. Molecular cloning and expression of a novel beta-1,6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches. J. Biol. Chem. 274, 3215\u20133221 (1999).","journal-title":"J. Biol. Chem."},{"key":"26468_CR15","first-page":"521","volume":"23","author":"T Komori","year":"2004","unstructured":"Komori, T. et al. Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray. J. Exp. Clin. Cancer Res. CR 23, 521\u2013527 (2004).","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"26468_CR16","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3892\/or.2015.4196","volume":"34","author":"T Nakao","year":"2015","unstructured":"Nakao, T. et al. Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer. Oncol. Rep. 34, 1961\u20131967 (2015).","journal-title":"Oncol. Rep."},{"key":"26468_CR17","doi-asserted-by":"publisher","first-page":"e98556","DOI":"10.1371\/journal.pone.0098556","volume":"9","author":"M Gonz\u00e1lez-Vallinas","year":"2014","unstructured":"Gonz\u00e1lez-Vallinas, M. et al. Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancer. PloS One 9, e98556 (2014).","journal-title":"PloS One"},{"key":"26468_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-2-23","volume":"2","author":"G Fedorowicz","year":"2009","unstructured":"Fedorowicz, G., Guerrero, S., Wu, T. D. & Modrusan, Z. Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas. BMC Med. Genomics 2, 23 (2009).","journal-title":"BMC Med. Genomics"},{"key":"26468_CR19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5858\/1999-123-0909-COGEBO","volume":"123","author":"HA Multhaupt","year":"1999","unstructured":"Multhaupt, H. A., Arenas-Elliott, C. P. & Warhol, M. J. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch. Pathol. Lab. Med. 123, 909\u2013916 (1999).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"26468_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","volume":"130","author":"KA Lowe","year":"2013","unstructured":"Lowe, K. A. et al. An international assessment of ovarian cancer incidence and mortality. Gynecol. Oncol. 130, 107\u2013114 (2013).","journal-title":"Gynecol. Oncol."},{"key":"26468_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","volume":"40","author":"CB Gilks","year":"2009","unstructured":"Gilks, C. B. & Prat, J. Ovarian carcinoma pathology and genetics: recent advances. Hum. Pathol. 40, 1213\u20131223 (2009).","journal-title":"Hum. Pathol."},{"key":"26468_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu, P. P. & Sabatini, D. M. Cancer cell metabolism: Warburg and beyond. Cell 134, 703\u2013707 (2008).","journal-title":"Cell"},{"key":"26468_CR23","first-page":"179","volume":"41","author":"N Bou Zgheib","year":"2012","unstructured":"Bou Zgheib, N. et al. The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer. Int. J. Oncol. 41, 179\u2013188 (2012).","journal-title":"Int. J. Oncol."},{"key":"26468_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","volume":"31","author":"S Masoumi Moghaddam","year":"2012","unstructured":"Masoumi Moghaddam, S., Amini, A., Morris, D. L. & Pourgholami, M. H. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev. 31, 143\u2013162 (2012).","journal-title":"Cancer Metastasis Rev."},{"key":"26468_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10555-014-9538-9","volume":"34","author":"H-J Choi","year":"2015","unstructured":"Choi, H.-J. et al. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev. 34, 19\u201340 (2015).","journal-title":"Cancer Metastasis Rev."},{"key":"26468_CR26","first-page":"bat013","volume":"2013","author":"BF Ganzfried","year":"2013","unstructured":"Ganzfried, B. F. et al. Curated ovariandata: clinically annotated data for the ovarian cancer transcriptome. Database J. Biol. Databases Curation 2013, bat013 (2013).","journal-title":"Database J. Biol. Databases Curation"},{"key":"26468_CR27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/00000658-195406000-00015","volume":"139","author":"VB Astler","year":"1954","unstructured":"Astler, V. B. & Coller, F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg. 139, 846\u2013852 (1954).","journal-title":"Ann. Surg."},{"key":"26468_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00404-014-3364-8","volume":"290","author":"F Zeppernick","year":"2014","unstructured":"Zeppernick, F. & Meinhold-Heerlein, I. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer. Arch. Gynecol. Obstet. 290, 839\u2013842 (2014).","journal-title":"Arch. Gynecol. Obstet."},{"key":"26468_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge, S. B. & Compton, C. C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471\u20131474 (2010).","journal-title":"Ann. Surg. Oncol."},{"key":"26468_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep11966","volume":"5","author":"E Martinez-Ledesma","year":"2015","unstructured":"Martinez-Ledesma, E., Verhaak, R. G. W. & Trevi\u00f1o, V. Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm. Sci. Rep. 5, 11966 (2015).","journal-title":"Sci. Rep."},{"key":"26468_CR31","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1128\/MCB.00204-09","volume":"29","author":"EL Stone","year":"2009","unstructured":"Stone, E. L. et al. Glycosyltransferase function in core 2-type protein O glycosylation. Mol. Cell. Biol. 29, 3770\u20133782 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"26468_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep26451","volume":"6","author":"J Ashkani","year":"2016","unstructured":"Ashkani, J. & Naidoo, K. J. Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes. Sci. Rep. 6, 26451 (2016).","journal-title":"Sci. Rep."},{"key":"26468_CR33","first-page":"1551","volume":"13","author":"N Zhang","year":"2008","unstructured":"Zhang, N., Yin, Y., Xu, S.-J. & Chen, W.-S. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Mol. Basel Switz. 13, 1551\u20131569 (2008).","journal-title":"Mol. Basel Switz."},{"key":"26468_CR34","first-page":"61","volume":"72","author":"M Gonz\u00e1lez-Vallinas","year":"2013","unstructured":"Gonz\u00e1lez-Vallinas, M. et al. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol. Res. Off. J. Ital. Pharmacol. Soc. 72, 61\u201368 (2013).","journal-title":"Pharmacol. Res. Off. J. Ital. Pharmacol. Soc."},{"key":"26468_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of Cancer: The Next Generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"26468_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0014-4827(85)90427-6","volume":"158","author":"P Vischer","year":"1985","unstructured":"Vischer, P. & Buddecke, E. Alteration of glycosyltransferase activities during proliferation of cultivated arterial endothelial cells and smooth muscle cells. Exp. Cell Res. 158, 15\u201328 (1985).","journal-title":"Exp. Cell Res."},{"key":"26468_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2012.36","volume":"1","author":"S Olivier-Van Stichelen","year":"2012","unstructured":"Olivier-Van Stichelen, S. et al. Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression. Oncogenesis 1, e36 (2012).","journal-title":"Oncogenesis"},{"key":"26468_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cell.2010.12.030","volume":"144","author":"F Capotosti","year":"2011","unstructured":"Capotosti, F. et al. O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1. Cell 144, 376\u2013388 (2011).","journal-title":"Cell"},{"key":"26468_CR39","doi-asserted-by":"publisher","first-page":"34460","DOI":"10.1074\/jbc.M110.158170","volume":"285","author":"K Sakabe","year":"2010","unstructured":"Sakabe, K. & Hart, G. W. O-GlcNAc Transferase Regulates Mitotic Chromatin Dynamics. J. Biol. Chem. 285, 34460\u201334468 (2010).","journal-title":"J. Biol. Chem."},{"key":"26468_CR40","first-page":"169","volume":"10","author":"J Nagata","year":"2002","unstructured":"Nagata, J. et al. Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer. Int. J. Mol. Med. 10, 169\u2013172 (2002).","journal-title":"Int. J. Mol. Med."},{"key":"26468_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben, A. et al. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549\u2013580 (2004).","journal-title":"Pharmacol. Rev."},{"key":"26468_CR42","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/onc.2010.496","volume":"30","author":"S Samuel","year":"2011","unstructured":"Samuel, S. et al. Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells. Oncogene 30, 1205\u20131212 (2011).","journal-title":"Oncogene"},{"key":"26468_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast","year":"2009","unstructured":"Bast, R. C., Hennessy, B. & Mills, G. B. The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 9, 415 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"26468_CR44","doi-asserted-by":"publisher","first-page":"38719","DOI":"10.18632\/oncotarget.5340","volume":"6","author":"R S\u00e1nchez-Mart\u00ednez","year":"2015","unstructured":"S\u00e1nchez-Mart\u00ednez, R. et al. A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy. Oncotarget 6, 38719\u201338736 (2015).","journal-title":"Oncotarget"},{"key":"26468_CR45","unstructured":"Oliveros, J. C. FIESTA@BioinfoGP. An interactive server for analyzing DNA microarray experiments with replicates, http:\/\/bioinfogp.cnb.csic.es\/tools\/FIESTA (2007)."},{"key":"26468_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-1-r3","volume":"8","author":"P Carmona-Saez","year":"2007","unstructured":"Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M. & Pascual-Montano, A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 8, R3 (2007).","journal-title":"Genome Biol."},{"key":"26468_CR47","doi-asserted-by":"publisher","first-page":"W317","DOI":"10.1093\/nar\/gkp416","volume":"37","author":"R Nogales-Cadenas","year":"2009","unstructured":"Nogales-Cadenas, R. et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 37, W317\u2013322 (2009).","journal-title":"Nucleic Acids Res."},{"key":"26468_CR48","doi-asserted-by":"publisher","first-page":"W478","DOI":"10.1093\/nar\/gks402","volume":"40","author":"D Tabas-Madrid","year":"2012","unstructured":"Tabas-Madrid, D., Nogales-Cadenas, R. & Pascual-Montano, A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 40, W478\u2013483 (2012).","journal-title":"Nucleic Acids Res."},{"key":"26468_CR49","doi-asserted-by":"publisher","first-page":"e21800","DOI":"10.1371\/journal.pone.0021800","volume":"6","author":"F Supek","year":"2011","unstructured":"Supek, F., Bo\u0161njak, M., \u0160kunca, N. & \u0160muc, T. REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms. Plos One 6, e21800 (2011).","journal-title":"Plos One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26468-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:06:42Z","timestamp":1671602802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26468-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26468"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26468-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8485"}}